The overexpression of D3R in the D1R-enriched direct GABA pathway in the context of DA denervation and intermittent l-DOPA therapy seems to contribute to causing D1R sensitization and the development of l-DOPA-induced dyskinesias [76,267]. Here, DRD1 is linked to Dyskinesia.